利润表（瑞康医药）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 6,056,194,532.51 | 4,031,665,203.80 | 2,018,758,765.18 | 8,034,367,997.33 | 6,105,062,530.67 | 4,079,932,498.77 | 2,073,027,669.16 |
| 营业收入(元) | 6,056,194,532.51 | 4,031,665,203.80 | 2,018,758,765.18 | 8,034,367,997.33 | 6,105,062,530.67 | 4,079,932,498.77 | 2,073,027,669.16 |
| 二、营业总成本(元) | 5,997,705,441.86 | 3,997,336,554.85 | 2,023,237,316.54 | 8,240,564,392.56 | 6,210,217,250.06 | 4,183,994,764.22 | 2,081,916,966.47 |
| 营业成本(元) | 5,265,530,452.49 | 3,525,841,738.41 | 1,775,624,876.88 | 7,207,335,794.48 | 5,286,626,511.54 | 3,546,769,335.88 | 1,753,394,409.58 |
| 研发费用(元) | 7,566,022.65 | 5,479,545.12 | 3,103,612.68 | 14,615,574.10 | 10,177,007.27 | 6,264,217.06 | 2,846,655.14 |
| 营业税金及附加(元) | 26,800,898.10 | 17,069,856.86 | 7,351,008.64 | 45,716,524.02 | 37,264,388.23 | 17,362,677.02 | 9,464,728.67 |
| 销售费用(元) | 275,357,168.85 | 190,452,112.10 | 89,882,828.94 | 431,996,741.55 | 375,533,520.33 | 259,367,477.51 | 102,338,007.79 |
| 管理费用(元) | 293,252,275.18 | 175,152,600.54 | 91,616,188.40 | 408,259,565.59 | 334,883,448.28 | 219,247,951.74 | 94,926,386.03 |
| 财务费用(元) | 129,198,624.59 | 83,340,701.82 | 55,658,801.00 | 132,640,192.82 | 165,732,374.41 | 134,983,105.01 | 118,946,779.26 |
| 其中：利息费用(元) | 166,706,929.51 | 108,093,221.28 | 67,541,143.52 | 303,702,002.77 | 247,760,196.17 | 167,607,654.66 | 122,639,152.60 |
| 其中：利息收入(元) | 59,335,714.37 | 44,112,222.96 | 29,091,508.25 | 190,709,173.68 | 101,485,700.53 | 53,314,073.72 | 23,538,527.00 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 12,464,457.63 | - | - | -228,896,122.98 | -277,419,700.00 | -179,378,500.00 | -32,640,000.00 |
| 加：投资收益(元) | 29,014,904.55 | 32,150,163.64 | 5,003,521.62 | 408,821,559.90 | 416,512,053.59 | 318,348,963.29 | 53,288,290.22 |
| 其中：对联营企业和合营企业的投资收益(元) | - | - | - | -6,068,219.81 | - | - | - |
| 资产处置收益(元) | -6,467,871.93 | -5,899,298.78 | -5,950,298.85 | -7,924,504.83 | 2,743,010.05 | 2,717,112.30 | 2,668,716.19 |
| 资产减值损失(元) | 708,089.19 | 708,089.19 | - | -33,485,159.48 | - | - | - |
| 信用减值损失(元) | -42,741,474.43 | -19,570,124.70 | 31,772,247.10 | -67,735,303.51 | 12,904,000.84 | 25,803,409.77 | 16,451,497.77 |
| 其他收益(元) | 1,869,258.50 | 1,371,992.65 | 36,631.62 | 8,780,489.74 | 1,519,481.15 | 1,403,263.08 | 2,098,533.84 |
| 四、营业利润(元) | 53,336,454.16 | 43,089,470.95 | 26,383,550.13 | -126,635,436.39 | 51,104,126.24 | 64,831,982.99 | 32,977,740.71 |
| 加：营业外收入(元) | 1,850,298.04 | 982,757.83 | 262,131.13 | 2,932,969.92 | 4,615,394.74 | 2,987,364.68 | 1,192,715.93 |
| 减：营业外支出(元) | 8,072,922.87 | 3,886,179.09 | 2,234,859.15 | 11,715,249.83 | 22,458,728.82 | 714,931.10 | 1,233,874.95 |
| 五、利润总额(元) | 47,113,829.33 | 40,186,049.69 | 24,410,822.11 | -135,417,716.30 | 33,260,792.16 | 67,104,416.57 | 32,936,581.69 |
| 减：所得税费用(元) | -5,135,191.98 | -365,935.21 | 5,839,723.31 | -167,388,950.92 | 5,428,772.56 | 25,517,984.82 | 2,953,133.65 |
| 六、净利润(元) | 52,249,021.31 | 40,551,984.90 | 18,571,098.80 | 31,971,234.62 | 27,832,019.60 | 41,586,431.75 | 29,983,448.04 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 52,249,021.31 | 40,551,984.90 | 18,571,098.80 | 31,971,234.62 | 27,832,019.60 | 41,586,431.75 | 29,983,448.04 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 38,806,313.59 | 31,025,324.74 | 15,168,972.69 | 20,317,689.35 | 19,220,119.06 | 30,667,269.81 | 21,159,565.23 |
| 少数股东损益(元) | 13,442,707.72 | 9,526,660.16 | 3,402,126.11 | 11,653,545.27 | 8,611,900.54 | 10,919,161.94 | 8,823,882.81 |
| 扣除非经常性损益后的净利润(元) | 8,276,900.24 | 6,207,108.97 | 18,162,174.56 | -209,822,896.22 | -105,027,068.29 | -113,269,475.79 | -4,256,424.09 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| 二、稀释每股收益(元) | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| 九、综合收益总额(元) | 52,249,021.31 | 40,551,984.90 | 18,571,098.80 | 31,971,234.62 | 27,832,019.60 | 41,586,431.75 | 29,983,448.04 |
| 归属于母公司所有者的综合收益总额(元) | 38,806,313.59 | 31,025,324.74 | 15,168,972.69 | 20,317,689.35 | 19,220,119.06 | 30,667,269.81 | 21,159,565.23 |
| 归属于少数股东的综合收益总额(元) | 13,442,707.72 | 9,526,660.16 | 3,402,126.11 | 11,653,545.27 | 8,611,900.54 | 10,919,161.94 | 8,823,882.81 |
| 公告日期 | 2024-10-31 | 2024-08-27 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-30 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 42 of 42 entries